Exact Sciences Corp (EXAS)-Financial and Strategic SWOT Analysis Review
April 2017
39
About the Report
About the Report
Exact Sciences Corp (EXAS)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of colorectal cancer. The company's product portfolio includes screening tests such as Cologuard test, a non-invasive stool-based deoxyribonucleic acid (DNA) screening product. Cologuard is indicated to screen adults aged 50 years or older, who are at average risk for colorectal cancer. The Cologuard test also includes protein markers to detect blood in the stool, using an antibody based fecal immunochemical test. It intends to extend its patent portfolio to other diagnostic tests to detect esophageal, pancreatic and lung cancers. The company operates a laboratory facility to process Cologuard tests in Madison, Wisconsin. Exact is headquartered in Madison, Wisconsin, the US.
Exact Sciences Corp Key Recent Developments
Nov 08,2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer
Feb 24,2016: Exact Sciences Reports Fourth Quarter and Full Year 2015 Results
Jan 25,2016: Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors
Jan 11,2016: Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Companies
Quest Diagnostics Inc Illumina, Inc. GeneNews Ltd Everist Genomics Inc Epigenomics AG EDP Biotech Corporation Applied Proteomics Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
Exact Sciences Corp-Key Facts 5
Exact Sciences Corp-Key Employees 6
Exact Sciences Corp-Key Employee Biographies 7
Exact Sciences Corp-Major Products and Services 8
Exact Sciences Corp-History 9
Exact Sciences Corp-Company Statement 11
Exact Sciences Corp-Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2-Company Analysis 15
Exact Sciences Corp-Business Description 15
Exact Sciences Corp-Corporate Strategy 16
Exact Sciences Corp-SWOT Analysis 17
SWOT Analysis-Overview 17
Exact Sciences Corp-Strengths 17
Exact Sciences Corp-Weaknesses 18
Exact Sciences Corp-Opportunities 19
Exact Sciences Corp-Threats 20
Exact Sciences Corp-Key Competitors 21
Section 3-Company Financial Ratios 22
Financial Ratios-Capital Market Ratios 22
Financial Ratios-Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios-Interim Ratios 26
Financial Ratios-Ratio Charts 27
Section 4-Company's Lifesciences Financial Deals and Alliances 28
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Exact Sciences Corp, Recent Deals Summary 30
Section 5-Company's Recent Developments 31
Nov 08, 2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer 31
Feb 24, 2016: Exact Sciences Reports Fourth Quarter and Full Year 2015 Results 32
Jan 25, 2016: Exact Sciences announces appointment of John A. Fallon, M.D., to company's board of directors 33
Jan 11, 2016: Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results 34
Section 6-Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Figure
List of Figures
Exact Sciences Corp, Performance Chart (2012-2016) 25
Exact Sciences Corp, Ratio Charts 27
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29
List of Table
List of Tables
Exact Sciences Corp, Key Facts 5
Exact Sciences Corp, Key Employees 6
Exact Sciences Corp, Key Employee Biographies 7
Exact Sciences Corp, Major Products and Services 8
Exact Sciences Corp, History 9
Exact Sciences Corp, Subsidiaries 14
Exact Sciences Corp, Key Competitors 21
Exact Sciences Corp, Ratios based on current share price 22
Exact Sciences Corp, Annual Ratios 23
Exact Sciences Corp, Annual Ratios (Cont...1) 24
Exact Sciences Corp, Interim Ratios 26
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Exact Sciences Corp, Recent Deals Summary 30
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.